Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia
Clinical trial NCT04485052 · SUSPENDED
Trial details
- NCT number
- NCT04485052
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2024-06-30
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.